| Akcje zaległe | 11,617,250 shares |
| Akcje insidera | 102 563 537 shares |
| Insiderzy ogółem | 19 |
Wynik sentymentu insiderów
Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.
Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.
Częstotliwość aktualizacji: codziennie
Ocena sentymentu kadry kierowniczej
Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.
Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.
Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.
Częstotliwość aktualizacji: codziennie
Kluczowe wskaźniki insider
Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.
Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.
Liczba netto zakupów dokonanych przez insiderów (ranking)
9127 out of 10948
Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).
Procent akcji kupowanych przez insiderów (ranking)
9031 out of 10786
Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.
Wykres handlu insider
Poniższy wykres przedstawia Phio Pharmaceuticals Corp. transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.
Lista insiderów i wskaźniki rentowności
Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
| Advanced RNA Technologies, LLC - | 1 221 723 | 1 221 723 | |
| Patricia A Bradford Director - [D] | 45 651 | 45 651 | |
| John A Barrett Chief Development Officer - [O] | 222 991 | 8 802 | |
| Robert J Bitterman Chairman, Pres. & CEO, Director - [D] [O] | 411 421 | 411 421 | |
| Keith L Brownlie Director - [D] | 20 000 | 789 | |
| Geert Cauwenbergh Director - [D] | 4 235 | 471 |
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
| Lisa Cabott Carson Chief Financial Officer - [O] | 94 000 | 94 000 | |
| David H Deming Director - [D] | 37 800 | 37 800 | |
| Gerrit Dispersyn President & CEO, Director - [D] [O] | 212 327 | 20 222 | |
| Dorman H. Paul Director - [D] | 20 370 | 1 940 | |
| Alexey Eliseev Chief Business Officer - [O] | 950 312 | 950 312 | |
| Robert L Ferrara Director - [D] | 38 766 | 38 766 |
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
| Jonathan E Freeman Director - [D] | 32 655 | 32 655 | |
|
Galena Biopharma, Inc.
10% Owner -
|
32 393 095 | 32 393 095 | |
| Infarinato Robert M. VP, CFO - [O] | 11 000 | 11 000 | |
| Caitlin Kontulis Secretary & VP Finance & Admin - [O] | 10 643 | 1 183 | |
| Curtis Lockshin Director - [D] | 35 155 | 35 155 | |
|
Opko Health, Inc.
10% Owner -
|
67 241 380 | 67 241 380 | |
| Pamela Pavco Chief Development Officer - [O] | 17 173 | 17 173 |
Report errors via our new Insider Auditing Tool
Śledź historię zakupów insiderów — analiza zysków krótkoterminowych
W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w PHIO / Phio Pharmaceuticals Corp.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Śledź historię sprzedaży insider — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w PHIO / Phio Pharmaceuticals Corp.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia transakcji
Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.
| Plik Data |
Data transakcji |
Formularz | Wtajemniczony | Serce | Nazwa papieru wartościowego | Kod | Bezpośredni | Cena wykonania |
Cena jednostki |
Zmieniono jednostki |
Zmieniona wartość (1 tys.) |
Pozostałe opcje |
Pozostałe akcje |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-05 | 4 | Freeman Jonathan E | PHIO | Common Stock, $.0001 par value | D | 16 600 | 32 655 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Lockshin Curtis | PHIO | Common Stock, $.0001 par value | D | 16 600 | 35 155 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Carson Lisa Cabott | PHIO | Common Stock, $.0001 par value | D | 47 000 | 94 000 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Deming David H | PHIO | Common Stock, $.0001 par value | D | 23 800 | 37 800 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $.0001 par value | D | 18 500 | 45 651 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 120 000 | 411 421 | ||||||
| 2026-01-02 | 2025-12-31 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,0300 | 5 000 | 5 | 291 421 | ||||
| 2025-12-29 | 2025-12-23 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,0200 | 5 000 | 5 | 286 421 | ||||
| 2025-11-24 | 2025-11-21 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,1400 | 5 000 | 6 | 281 421 | ||||
| 2025-11-19 | 2025-11-18 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,2700 | 5 000 | 6 | 276 421 | ||||
| 2025-09-15 | 2025-09-11 | 4/A | Ferrara Robert L | PHIO | Common Stock, $.0001 par value | D | 23 100 | 38 766 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Deming David H | PHIO | Common Stock, $.0001 par value | D | 14 000 | 14 000 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Ferrara Robert L | PHIO | Common Stock, $.0001 par value | D | 23 000 | 38 666 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Freeman Jonathan E | PHIO | Common Stock, $.0001 par value | D | 14 700 | 16 055 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Lockshin Curtis | PHIO | Common Stock, $.0001 par value | D | 16 200 | 18 555 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $.0001 par value | D | 18 800 | 27 151 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Carson Lisa Cabott | PHIO | Common Stock, $.0001 par value | D | 47 000 | 47 000 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 250 000 | 271 421 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 2,3200 | -4 111 | -10 | 21 421 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 2,4199 | 2 500 | 6 | 15 666 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 2,4200 | 2 000 | 5 | 27 149 | ||||
| 2025-06-10 | 2025-06-09 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 2,7500 | 1 500 | 4 | 25 149 | ||||
| 2025-05-23 | 2025-05-22 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 1,7799 | 1 200 | 2 | 23 649 | ||||
| 2025-05-23 | 2025-05-21 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 1,7700 | 3 000 | 5 | 22 449 | ||||
| 2025-05-21 | 2025-05-20 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 1,8200 | 2 500 | 5 | 13 166 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 15 500 | 17 832 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | Freeman Jonathan E | PHIO | Common Stock, $0.0001 par value | D | 1 000 | 1 000 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | Infarinato Robert M. | PHIO | Common Stock, $0.0001 Par Value | D | 3 000 | 11 000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Lockshin Curtis | PHIO | Common Stock, $0.0001 par value | D | 2 000 | 2 000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $0.0001 par value | D | 8 000 | 8 000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10 000 | 10 000 | ||||||
| 2024-08-15 | 2024-08-13 | 4 | Infarinato Robert M. | PHIO | Common stock, $0.0001 par value | D | 8 000 | 8 000 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7400 | 1 000 | 1 | 20 990 | ||||
| 2024-06-10 | 2024-06-06 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7500 | 1 000 | 1 | 19 990 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,9580 | -335 | -0 | 10 643 | ||||
| 2024-02-27 | 2024-02-26 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,9100 | 2 500 | 2 | 18 990 | ||||
| 2024-02-22 | 2024-02-20 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7600 | -1 804 | -1 | 16 490 | ||||
| 2024-02-20 | 2024-02-17 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,6600 | -523 | -0 | 10 978 | ||||
| 2024-02-20 | 2024-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,6500 | -658 | -0 | 11 501 | ||||
| 2023-10-03 | 2023-10-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 1,5100 | -917 | -1 | 18 294 | ||||
| 2023-07-05 | 2023-07-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 2,8400 | 1 000 | 3 | 19 211 | ||||
| 2023-07-05 | 2023-06-30 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 2,8800 | 1 000 | 3 | 18 211 | ||||
| 2023-06-15 | 2023-06-14 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 3,1000 | 2 000 | 6 | 6 000 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 5,4900 | -335 | -2 | 12 159 | ||||
| 2023-02-22 | 2023-02-17 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 1 500 | 3 197 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | BRADFORD PATRICIA A | PHIO | Common stock, $0.0001 par value | D | 1 500 | 3 167 | ||||||
| 2023-02-22 | 2023-02-20 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 11 000 | 17 211 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 1 500 | 4 000 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 1 500 | 4 235 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 4 500 | 12 494 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 1 500 | 3 197 | ||||||
| 2023-02-17 | 2023-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 5,2000 | -657 | -3 | 7 994 | ||||
| 2022-12-15 | 2022-12-14 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,3900 | 2 000 | 1 | 74 541 | ||||
| 2022-12-08 | 2022-12-07 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,3900 | 2 000 | 1 | 72 541 | ||||
| 2022-12-06 | 2022-12-05 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4300 | 2 000 | 1 | 70 541 | ||||
| 2022-12-05 | 2022-12-02 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,4082 | 5 000 | 2 | 30 000 | ||||
| 2022-11-29 | 2022-11-29 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4000 | 215 | 0 | 68 541 | ||||
| 2022-11-29 | 2022-11-25 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4200 | 2 500 | 1 | 68 326 | ||||
| 2022-11-28 | 2022-11-23 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,4099 | 2 000 | 1 | 25 000 | ||||
| 2022-11-16 | 2022-11-16 | 4 | Bitterman Robert J | PHIO | Series D Preferred Stock, $0.0001 par value | D | 1 750,0000 | 1 | 2 | 1 | ||||
| 2022-10-03 | 2022-10-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 40 000 | 65 826 | ||||||
| 2022-09-26 | 2022-08-09 | 4 | BRADFORD PATRICIA A | PHIO | Common stock, $0.0001 par value | D | 20 000 | 20 000 | ||||||
| 2022-03-03 | 2022-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,8210 | -4 011 | -3 | 103 815 | ||||
| 2022-03-03 | 2022-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,8210 | -8 954 | -7 | 212 327 | ||||
| 2022-02-16 | 2022-02-15 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 10 000 | 20 366 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 68 000 | 107 826 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 10 000 | 20 364 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10 000 | 23 000 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Dorman H. Paul | PHIO | Common stock, $0.0001 par value | D | 10 000 | 20 370 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 126 000 | 221 281 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 10 000 | 32 822 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 10 000 | 25 826 | ||||||
| 2021-08-17 | 2021-08-16 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 1,6300 | 6 000 | 10 | 95 281 | ||||
| 2021-03-05 | 2021-03-04 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,5600 | 1 953 | 5 | 89 281 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 10 000 | 15 826 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 10 000 | 10 364 | ||||||
| 2021-03-03 | 2021-03-03 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 3,1500 | 682 | 2 | 13 000 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10 000 | 12 318 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 10 000 | 10 366 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 10 000 | 22 822 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Dorman H. Paul | PHIO | Common stock, $0.0001 par value | D | 10 000 | 10 370 | ||||||
| 2021-03-03 | 2021-03-03 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 3,0300 | 2 500 | 8 | 87 328 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 68 450 | 84 828 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 34 600 | 39 826 | ||||||
| 2020-08-19 | 2020-08-19 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,5000 | 2 000 | 5 | 16 377 | ||||
| 2020-03-03 | 2020-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,9300 | -673 | -2 | 14 628 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 237 500 | 24 | 279 030 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 350 000 | 35 | 827 817 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 300 000 | 30 | 320 440 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 127 500 | 13 | 127 500 | ||||
| 2019-11-20 | 2019-11-18 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 225 000 | 22 | 704 841 | ||||
| 2019-08-02 | 2019-08-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -749 | -0 | 41 530 | ||||
| 2019-08-02 | 2019-08-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -1 236 | -0 | 477 817 | ||||
| 2019-08-02 | 2019-08-01 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -1 751 | -1 | 479 841 | ||||
| 2019-04-24 | 2019-04-22 | 4 | Barrett John A | PHIO | Common stock, $0.0001 par value | D | 222 991 | 222 991 | ||||||
| 2019-03-05 | 2019-03-01 | 4 | Dispersyn Gerrit | PHIO | Common Stock | D | 407 703 | 479 053 | ||||||
| 2019-03-01 | 2019-02-28 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3798 | 152 415 | 58 | 481 592 | ||||
| 2019-02-19 | 2019-02-15 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3634 | 22 279 | 8 | 329 177 | ||||
| 2019-02-15 | 2019-02-13 | 4 | Dorman H. Paul | PHIO | Common stock | D | 10 000 | 20 375 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Lockshin Curtis | PHIO | Common stock | D | 10 000 | 20 130 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Freeman Jonathan E | PHIO | Common stock | D | 10 000 | 20 000 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Dispersyn Gerrit | PHIO | Common stock | D | 55 000 | 71 350 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Kontulis Caitlin | PHIO | Common stock | D | 27 000 | 40 214 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Bitterman Robert J | PHIO | Common stock | D | 10 000 | 20 440 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Brownlie Keith L | PHIO | Common stock | D | 10 000 | 20 000 | ||||||
| 2019-02-04 | 2019-02-01 | 4 | CAUWENBERGH GEERT | PHIO | Common Stock, $0.0001 par value | D | 0,3771 | 21 470 | 8 | 306 898 | ||||
| 2019-01-22 | 2019-01-18 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3412 | 23 729 | 8 | 285 428 | ||||
| 2019-01-07 | 2019-01-04 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3499 | 23 139 | 8 | 261 699 | ||||
| 2018-12-26 | 2018-12-21 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,2950 | 27 445 | 8 | 238 560 | ||||
| 2018-12-10 | 2018-12-07 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3700 | 21 882 | 8 | 211 115 | ||||
| 2018-11-26 | 2018-11-23 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3121 | 25 941 | 8 | 189 233 | ||||
| 2018-11-13 | 2018-11-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4330 | 18 698 | 8 | 163 292 | ||||
| 2018-10-29 | 2018-10-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4372 | 18 519 | 8 | 144 594 | ||||
| 2018-10-15 | 2018-10-12 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4699 | 17 230 | 8 | 126 075 | ||||
| 2018-10-01 | 2018-09-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,1700 | 73 587 | 86 | 108 845 | ||||
| 2018-08-03 | 2018-08-01 | 4 | Dorman H. Paul | RXII | Common Stock | D | 10 000 | 10 375 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Freeman Jonathan E | RXII | Common Stock | D | 10 000 | 10 000 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Lockshin Curtis | RXII | Common Stock | D | 10 000 | 10 130 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 1,79 | 10 500 | 10 500 | |||||
| 2018-08-03 | 2018-08-01 | 4 | Kontulis Caitlin | RXII | Common Stock | D | 10 500 | 11 024 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Dispersyn Gerrit | RXII | Stock option (right to buy) | D | 1,79 | 16 000 | 16 000 | |||||
| 2018-08-03 | 2018-08-01 | 4 | Dispersyn Gerrit | RXII | Common Stock | D | 16 000 | 16 350 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 1,79 | 21 000 | 21 000 | |||||
| 2018-08-03 | 2018-08-01 | 4 | CAUWENBERGH GEERT | RXII | Common Stock | D | 21 000 | 35 258 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Bitterman Robert J | RXII | Common Stock | D | 10 000 | 10 440 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Brownlie Keith L | RXII | Common Stock | D | 10 000 | 10 000 | ||||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4500 | 7 100 | 3 | 142 583 | ||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4600 | 200 | 0 | 135 483 | ||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4400 | 2 700 | 1 | 135 283 | ||||
| 2017-09-07 | 2017-09-07 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5283 | -58 712 | -31 | 950 312 | ||||
| 2017-09-07 | 2017-09-06 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5365 | -91 907 | -49 | 1 009 024 | ||||
| 2017-09-07 | 2017-09-05 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5571 | -26 181 | -15 | 1 100 931 | ||||
| 2017-09-01 | 2017-09-01 | 4 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 0,5682 | -23 200 | -13 | 1 127 112 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5600 | 739 | 0 | 132 583 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5500 | 4 361 | 2 | 131 844 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5450 | 4 900 | 3 | 127 483 | ||||
| 2017-06-26 | 2017-06-23 | 4 | Dispersyn Gerrit | RXII | Common stock, $0.0001 par value | D | 0,6200 | 3 500 | 2 | 3 500 | ||||
| 2017-06-22 | 2017-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6200 | 5 000 | 3 | 122 583 | ||||
| 2017-06-22 | 2017-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6300 | 5 000 | 3 | 117 583 | ||||
| 2017-06-09 | 2017-06-09 | 4 | Eliseev Alexey | RXII | Series C Convertible Preferred Stock, $0.0001 par value | D | -332 499 | 0 | ||||||
| 2017-06-09 | 2017-06-09 | 4 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 332 499 | 1 150 312 | ||||||
| 2017-06-07 | 2017-06-06 | 4 | Freeman Jonathan E | RXII | Stock option (right to buy) | D | 0,54 | 3 500 | 3 500 | |||||
| 2017-04-26 | 2017-04-24 | 4 | Dispersyn Gerrit | RXII | Stock option (right to buy) | D | 0,65 | 95 000 | 95 000 | |||||
| 2017-04-26 | 2017-04-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6480 | 10 000 | 6 | 112 583 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7655 | 15 | 0 | 102 583 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7651 | 665 | 1 | 102 568 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7695 | 9 320 | 7 | 101 903 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6950 | 2 917 | 2 | 92 583 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6924 | 6 883 | 5 | 89 666 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6915 | 200 | 0 | 82 783 | ||||
| 2017-02-08 | 2017-02-08 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6850 | 10 000 | 7 | 82 583 | ||||
| 2017-02-03 | 2017-02-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,63 | 13 000 | 13 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,63 | 7 000 | 7 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,63 | 2 000 | 2 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,63 | 2 000 | 2 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,63 | 2 000 | 2 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,63 | 2 500 | 2 500 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,63 | 2 000 | 2 000 | |||||
| 2017-01-26 | 2017-01-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6968 | 9 700 | 7 | 72 583 | ||||
| 2017-01-26 | 2017-01-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6900 | 300 | 0 | 62 883 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6949 | 600 | 0 | 62 583 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6946 | 3 000 | 2 | 61 983 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6950 | 6 400 | 4 | 58 983 | ||||
| 2017-01-17 | 3 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 1 635 626 | ||||||||
| 2017-01-17 | 3 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 1 635 626 | ||||||||
| 2017-01-03 | 2016-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7260 | 2 000 | 1 | 52 583 | ||||
| 2016-12-27 | 2016-12-23 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock, $0.0001 par value | I | 0,7190 | 3 000 | 2 | 4 500 | ||||
| 2016-12-23 | 2016-12-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7490 | 3 000 | 2 | 53 583 | ||||
| 2016-12-20 | 2016-12-16 | 4 | Pavco Pamela | RXII | Common stock warrant | D | 0,90 | 11 111 | 11 111 | |||||
| 2016-12-20 | 2016-12-16 | 4 | Pavco Pamela | RXII | Common stock, $0.0001 par value | D | 0,9000 | 11 111 | 10 | 17 173 | ||||
| 2016-12-20 | 2016-12-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock warrant | D | 0,90 | 33 333 | 33 333 | |||||
| 2016-12-20 | 2016-12-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,9000 | 33 333 | 30 | 50 583 | ||||
| 2016-02-12 | 2016-02-10 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,29 | 66 000 | 66 000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,29 | 133 000 | 133 000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,29 | 16 666 | 16 666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,29 | 16 666 | 16 666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,29 | 16 666 | 16 666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,29 | 20 000 | 20 000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,29 | 16 666 | 16 666 | |||||
| 2015-06-23 | 2015-06-22 | 4 | CAUWENBERGH GEERT | RXII | Overallotment purchase right | D | 0,46 | -35 000 | 0 | |||||
| 2015-06-23 | 2015-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4550 | 35 000 | 16 | 172 500 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Overallotment purchase rights | D | 0,46 | 18 750 | 18 750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Common stock warrants | D | 0,52 | 18 750 | 18 750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 0,4000 | 37 500 | 15 | 44 000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Overallotment purchase right | I | 0,46 | 5 000 | 5 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock warrant | I | 0,52 | 5 000 | 5 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock warrant | D | 0,52 | 35 000 | 35 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Overallotment purchase right | D | 0,46 | 35 000 | 35 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock, $0.0001 par value | I | 0,4000 | 10 000 | 4 | 15 000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4000 | 70 000 | 28 | 137 500 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Overallotment purchase right | D | 0,46 | 6 000 | 6 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Common stock warrant | D | 0,52 | 6 000 | 6 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Common stock, $0.0001 par value | D | 0,4000 | 12 000 | 5 | 13 000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Common stock purchase warrant | D | 0,52 | 6 250 | 6 250 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Overallotment purchase right | D | 0,46 | 6 250 | 6 250 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Common stock, $0.0001 par value | D | 0,4000 | 12 500 | 5 | 33 718 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Overallotment purchase right | D | 0,46 | 18 750 | 18 750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Common stock warrant | D | 0,52 | 18 750 | 18 750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Common stock, $0.0001 par value | D | 0,4000 | 37 500 | 15 | 37 500 | ||||
| 2015-06-02 | 2015-06-01 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,38 | 66 000 | 66 000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,38 | 133 000 | 133 000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,38 | 16 666 | 16 666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,38 | 16 666 | 16 666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,38 | 16 666 | 16 666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,38 | 10 000 | 10 000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,38 | 16 666 | 16 666 | |||||
| 2015-04-02 | 2015-04-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7192 | 5 000 | 4 | 67 500 | ||||
| 2015-02-18 | 2015-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,1700 | 4 000 | 5 | 62 500 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2499 | 1 156 | 1 | 58 500 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2400 | 644 | 1 | 57 344 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2200 | 200 | 0 | 56 700 | ||||
| 2015-01-23 | 2015-01-22 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 1,1900 | 1 853 | 2 | 6 500 | ||||
| 2015-01-23 | 2015-01-22 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 1,2000 | 3 147 | 4 | 4 647 | ||||
| 2015-01-20 | 2015-01-20 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,0300 | 10 000 | 10 | 56 500 | ||||
| 2014-12-31 | 2014-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 1,5893 | 500 | 1 | 46 500 | ||||
| 2014-12-31 | 2014-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 1,5867 | 2 000 | 3 | 46 000 | ||||
| 2014-10-14 | 2014-10-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,6799 | 3 000 | 5 | 44 000 | ||||
| 2014-09-23 | 2014-09-19 | 4 | CAUWENBERGH GEERT By child | RXII | Common stock, $0.0001 | I | 2,2000 | 4 500 | 10 | 4 500 | ||||
| 2014-09-16 | 2014-09-16 | 4 | CAUWENBERGH GEERT By Spouse | RXII | Common stock, $0.0001 par value | I | 2,0780 | 5 000 | 10 | 46 000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1900 | 2 000 | 4 | 41 000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1899 | 3 000 | 7 | 39 000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1799 | 5 000 | 11 | 36 000 | ||||
| 2014-08-04 | 2014-07-31 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 2,4800 | 400 | 1 | 1 221 723 | ||||
| 2014-07-17 | 2014-07-15 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 2,5000 | 1 000 | 2 | 31 000 | ||||
| 2014-07-09 | 2014-07-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,5699 | 1 400 | 4 | 30 000 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8600 | 300 | 1 | 28 600 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8599 | 1 000 | 3 | 28 300 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8500 | 700 | 2 | 27 300 | ||||
| 2014-06-26 | 2014-06-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0100 | 500 | 2 | 26 600 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9600 | 800 | 2 | 26 100 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0000 | 200 | 1 | 25 300 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9921 | 1 000 | 3 | 25 100 | ||||
| 2014-06-09 | 2014-06-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0499 | 800 | 2 | 24 100 | ||||
| 2014-06-09 | 2014-06-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0500 | 200 | 1 | 23 300 | ||||
| 2014-06-05 | 2014-06-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9715 | 1 000 | 3 | 23 100 | ||||
| 2014-06-05 | 2014-06-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9140 | 1 000 | 3 | 22 100 | ||||
| 2014-06-04 | 2014-06-02 | 4 | Bitterman Robert J | RXII | Stock Option (right to buy) | D | 2,85 | 16 666 | 16 666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Brownlie Keith L | RXII | Stock Option (right to buy) | D | 2,85 | 16 666 | 16 666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 2,85 | 16 666 | 16 666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | CAUWENBERGH GEERT | RXII | Stock Option (right to buy) | D | 2,85 | 133 000 | 133 000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Pavco Pamela | RXII | Stock Option (right to buy) | D | 2,85 | 66 000 | 66 000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Kontulis Caitlin | RXII | Stock Option (right to buy) | D | 2,85 | 10 000 | 10 000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 2,85 | 16 666 | 16 666 | |||||
| 2014-05-15 | 2014-04-22 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,1100 | -5 000 | -21 | 1 250 315 | ||||
| 2014-03-26 | 2014-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -2 000 | -12 | 1 255 315 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,5500 | -1 941 | -11 | 1 257 315 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,7000 | -1 000 | -6 | 1 259 256 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,6100 | -1 000 | -6 | 1 260 256 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,5500 | -59 | -0 | 1 261 256 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -1 400 | -9 | 1 261 315 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -500 | -3 | 1 262 715 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1100 | -100 | -1 | 1 263 215 | ||||
| 2014-03-26 | 2014-03-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -2 000 | -12 | 1 263 315 | ||||
| 2014-03-21 | 2014-02-28 | 4/A | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,2000 | -2 600 | -16 | 1 247 315 | ||||
| 2014-03-21 | 2014-02-27 | 4/A | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -400 | -2 | 1 276 915 | ||||
| 2014-03-11 | 2014-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,8000 | -2 000 | -12 | 1 265 315 | ||||
| 2014-03-11 | 2014-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,9100 | -2 000 | -12 | 1 267 315 | ||||
| 2014-03-11 | 2014-03-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1500 | -5 000 | -31 | 1 269 315 | ||||
| 2014-03-11 | 2014-02-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,2000 | 2 600 | 16 | 1 274 315 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | 400 | 2 | 1 276 915 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1100 | -1 300 | -8 | 1 277 315 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,4500 | -5 000 | -32 | 1 278 615 | ||||
| 2014-03-11 | 2014-02-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0300 | -400 | -2 | 1 283 615 | ||||
| 2014-03-11 | 2014-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,5500 | -5 000 | -33 | 1 284 015 | ||||
| 2014-03-11 | 2014-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -5 000 | -30 | 1 289 015 | ||||
| 2014-03-06 | 2014-02-24 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,3000 | -1 575 | -10 | 1 266 585 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,0000 | -5 000 | -25 | 1 268 160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,8500 | -5 000 | -24 | 1 273 160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,1500 | -5 000 | -26 | 1 278 160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,8000 | -576 | -3 | 1 283 160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7100 | -2 100 | -10 | 1 283 736 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7350 | -2 900 | -14 | 1 285 836 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7500 | -5 641 | -27 | 1 288 736 | ||||
| 2014-03-06 | 2014-02-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7000 | -1 200 | -6 | 1 294 377 | ||||
| 2013-11-01 | 2013-10-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,1900 | 800 | 3 | 21 100 | ||||
| 2013-11-01 | 2013-10-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0900 | 200 | 1 | 20 300 | ||||
| 2013-10-24 | 2013-10-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3400 | 1 000 | 3 | 20 100 | ||||
| 2013-10-22 | 2013-10-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4300 | 300 | 1 | 19 100 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 200 | 1 | 18 800 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3800 | 100 | 0 | 18 600 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,2900 | 100 | 0 | 18 500 | ||||
| 2013-10-16 | 2013-10-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5300 | 100 | 0 | 18 400 | ||||
| 2013-10-16 | 2013-10-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5100 | 100 | 0 | 18 300 | ||||
| 2013-10-16 | 2013-10-14 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5400 | 100 | 0 | 18 200 | ||||
| 2013-10-09 | 2013-10-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,1500 | 1 000 | 3 | 18 100 | ||||
| 2013-10-07 | 2013-10-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 200 | 1 | 17 100 | ||||
| 2013-10-07 | 2013-10-03 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5100 | 100 | 0 | 16 900 | ||||
| 2013-10-02 | 2013-09-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4200 | 300 | 1 | 16 800 | ||||
| 2013-09-26 | 2013-09-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 300 | 1 | 16 500 | ||||
| 2013-09-26 | 2013-09-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 100 | 0 | 16 200 | ||||
| 2013-09-24 | 2013-09-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 174 | 1 | 16 100 | ||||
| 2013-09-23 | 2013-09-20 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5200 | 326 | 1 | 15 926 | ||||
| 2013-09-19 | 2013-09-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4800 | 100 | 0 | 15 600 | ||||
| 2013-09-19 | 2013-09-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 100 | 0 | 15 500 | ||||
| 2013-09-17 | 2013-09-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 200 | 1 | 15 400 | ||||
| 2013-09-16 | 2013-09-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6000 | 100 | 0 | 15 200 | ||||
| 2013-09-16 | 2013-09-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 100 | 0 | 15 100 | ||||
| 2013-09-12 | 2013-09-11 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 150 | 1 | 15 000 | ||||
| 2013-09-12 | 2013-09-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5800 | 150 | 1 | 14 850 | ||||
| 2013-09-12 | 2013-09-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6500 | 200 | 1 | 14 700 | ||||
| 2013-09-03 | 2013-08-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3500 | 200 | 1 | 14 500 | ||||
| 2013-09-03 | 2013-08-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3800 | 100 | 0 | 14 300 | ||||
| 2013-08-30 | 2013-08-29 | 4 | Lockshin Curtis | RXII | Common stock, $0.0001 par value | D | 3,7000 | 1 000 | 4 | 1 000 | ||||
| 2013-08-30 | 2013-08-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 200 | 1 | 14 200 | ||||
| 2013-08-30 | 2013-08-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4000 | 200 | 1 | 14 000 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7000 | 100 | 0 | 13 800 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6000 | 100 | 0 | 13 700 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7500 | 200 | 1 | 13 600 | ||||
| 2013-08-28 | 2013-08-27 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7000 | 100 | 0 | 13 400 | ||||
| 2013-08-27 | 2013-08-26 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 3,9000 | 500 | 2 | 1 500 | ||||
| 2013-08-26 | 2013-08-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6900 | 200 | 1 | 13 300 | ||||
| 2013-08-26 | 2013-08-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7500 | 100 | 0 | 13 100 | ||||
| 2013-08-23 | 2013-08-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6200 | 300 | 1 | 13 000 | ||||
| 2013-08-22 | 2013-08-21 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,8000 | 680 | 3 | 12 700 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,7500 | 200 | 1 | 12 020 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,7000 | 200 | 1 | 11 820 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,9000 | 300 | 1 | 11 620 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6500 | 100 | 0 | 11 320 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6700 | 120 | 0 | 11 220 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,8600 | 100 | 0 | 11 100 | ||||
| 2013-08-06 | 2013-08-06 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0500 | 350 | 1 | 11 000 | ||||
| 2013-08-06 | 2013-08-05 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0300 | 150 | 1 | 10 650 | ||||
| 2013-08-06 | 2013-08-05 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0000 | 500 | 2 | 10 500 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0500 | 100 | 0 | 1 000 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0200 | 100 | 0 | 900 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0100 | 100 | 0 | 800 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0500 | 200 | 1 | 700 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,1300 | 500 | 2 | 500 | ||||
| 2013-07-31 | 2013-07-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,1000 | 500 | 2 | 9 833 | ||||
| 2013-07-31 | 2013-07-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0200 | 167 | 1 | 10 000 | ||||
| 2013-07-31 | 2013-07-23 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1580 | -28 000 | -4 | 38 820 446 | ||||
| 2013-07-30 | 2013-07-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,5400 | 500 | 2 | 9 333 | ||||
| 2013-07-29 | 2013-07-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,8700 | 500 | 2 | 8 833 | ||||
| 2013-07-22 | 2013-07-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1490 | -111 684 | -17 | 38 918 656 | ||||
| 2013-07-22 | 2013-07-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1535 | -100 000 | -15 | 38 960 130 | ||||
| 2013-07-22 | 2013-07-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1525 | -100 000 | -15 | 39 060 130 | ||||
| 2013-07-22 | 2013-07-17 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -100 000 | -16 | 39 160 130 | ||||
| 2013-07-15 | 2013-07-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -95 000 | -19 | 39 260 130 | ||||
| 2013-07-15 | 2013-07-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1990 | -5 000 | -1 | 39 355 130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -100 000 | -20 | 39 360 130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -100 000 | -20 | 39 360 130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1960 | -30 000 | -6 | 39 560 130 | ||||
| 2013-07-08 | 2013-07-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -18 180 | -4 | 39 590 130 | ||||
| 2013-07-08 | 2013-07-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -100 000 | -19 | 39 608 310 | ||||
| 2013-07-08 | 2013-07-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1945 | -50 000 | -10 | 39 708 310 | ||||
| 2013-07-08 | 2013-07-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -50 000 | -10 | 39 758 310 | ||||
| 2013-07-03 | 2013-07-02 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -30 000 | -6 | 39 808 310 | ||||
| 2013-07-03 | 2013-07-02 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1970 | -9 249 | -2 | 39 838 310 | ||||
| 2013-07-03 | 2013-07-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1970 | -50 000 | -10 | 39 847 559 | ||||
| 2013-07-03 | 2013-07-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1965 | -50 000 | -10 | 39 897 559 | ||||
| 2013-07-02 | 2013-06-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -46 874 | -9 | 39 947 559 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -45 000 | -9 | 39 994 433 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -60 000 | -12 | 40 039 433 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -50 000 | -10 | 40 099 433 | ||||
| 2013-07-02 | 2013-06-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -25 500 | -5 | 40 149 433 | ||||
| 2013-07-02 | 2013-06-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -50 000 | -10 | 40 174 933 | ||||
| 2013-07-02 | 2013-06-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -50 000 | -10 | 40 224 933 | ||||
| 2013-06-11 | 2013-06-07 | 4 | CAUWENBERGH GEERT | RXII | Stock Option (right to buy) | D | 0,20 | 4 000 000 | 4 000 000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Pavco Pamela | RXII | Stock Option (right to buy) | D | 0,20 | 2 000 000 | 2 000 000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Bitterman Robert J | RXII | Stock Option (right to buy) | D | 0,20 | 500 000 | 500 000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Brownlie Keith L | RXII | Stock Option (right to buy) | D | 0,20 | 500 000 | 500 000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Kontulis Caitlin | RXII | Stock Option (right to buy) | D | 0,20 | 300 000 | 300 000 | |||||
| 2013-05-03 | 2013-04-18 | 4/A | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 0,24 | 1 000 000 | 1 000 000 | |||||
| 2013-05-03 | 2013-04-18 | 4/A | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 0,24 | 1 000 000 | 1 000 000 | |||||
| 2013-05-02 | 2013-05-02 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,1905 | -253 000 | -48 | 32 393 095 | ||||
| 2013-05-02 | 2013-05-01 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,1925 | -659 500 | -127 | 32 646 095 | ||||
| 2013-05-02 | 2013-04-30 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,2138 | -171 000 | -37 | 33 305 595 | ||||
| 2013-04-23 | 2013-03-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3480 | -52 900 | -18 | 39 831 365 | ||||
| 2013-04-23 | 2013-03-15 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3250 | -100 000 | -32 | 39 884 265 | ||||
| 2013-04-23 | 2013-03-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3310 | -126 843 | -42 | 39 984 265 | ||||
| 2013-04-23 | 2013-03-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3340 | -7 500 | -3 | 40 111 108 | ||||
| 2013-04-23 | 2013-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2720 | -100 000 | -27 | 40 118 608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2730 | -100 000 | -27 | 40 218 608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2210 | -100 000 | -22 | 40 318 608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2400 | -100 000 | -24 | 40 418 608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2330 | -100 000 | -23 | 40 518 608 | ||||
| 2013-04-23 | 2013-03-08 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -50 000 | -10 | 40 618 608 | ||||
| 2013-04-23 | 2013-03-07 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -50 000 | -10 | 40 668 608 | ||||
| 2013-04-23 | 2013-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1490 | -36 570 | -5 | 40 718 608 | ||||
| 2013-04-23 | 2013-03-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1450 | -30 000 | -4 | 40 755 178 | ||||
| 2013-04-23 | 2013-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 | D | 0,1450 | -50 000 | -7 | 40 785 178 | ||||
| 2013-04-23 | 2013-03-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 | D | 0,1500 | -20 000 | -3 | 40 835 178 | ||||
| 2013-04-23 | 2013-02-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -200 | -0 | 40 855 178 | ||||
| 2013-04-23 | 2013-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -29 888 | -5 | 40 855 378 | ||||
| 2013-04-23 | 2013-02-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1750 | -4 000 | -1 | 40 885 266 | ||||
| 2013-04-23 | 2013-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1820 | -8 000 | -1 | 40 889 266 | ||||
| 2013-04-23 | 2013-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1800 | -92 000 | -17 | 40 897 266 | ||||
| 2013-04-23 | 2013-02-22 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -40 000 | -6 | 40 989 266 | ||||
| 2013-04-23 | 2013-02-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1920 | -1 000 | -0 | 41 029 266 | ||||
| 2013-04-23 | 2013-02-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1900 | -49 000 | -9 | 41 030 266 | ||||
| 2013-04-23 | 2013-02-15 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1360 | -40 000 | -5 | 41 079 266 | ||||
| 2013-04-23 | 2013-02-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1160 | -30 000 | -3 | 41 119 266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0910 | -20 000 | -2 | 41 149 266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0950 | -20 000 | -2 | 41 169 266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1150 | -40 000 | -5 | 41 189 266 | ||||
| 2013-04-23 | 2013-02-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0860 | -20 000 | -2 | 41 229 266 | ||||
| 2013-04-23 | 2013-02-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0760 | -10 000 | -1 | 41 249 266 | ||||
| 2013-04-23 | 2013-03-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2320 | -48 500 | -11 | 39 684 265 | ||||
| 2013-04-23 | 2013-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2310 | -57 100 | -13 | 39 732 765 | ||||
| 2013-04-23 | 2013-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2550 | -1 500 | -0 | 39 789 865 | ||||
| 2013-04-23 | 2013-03-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3000 | -40 000 | -12 | 39 791 365 | ||||
| 2013-04-22 | 2013-04-18 | 4 | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 0,24 | 1 000 000 | 1 000 000 | |||||
| 2013-04-22 | 2013-04-18 | 4 | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 0,24 | 1 000 000 | 1 000 000 | |||||
| 2013-03-19 | 3 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 41 259 266 | ||||||||
| 2013-03-13 | 3 | Opko Health, Inc. | RXII | Common Stock | D | 67 241 380 | ||||||||
| 2013-03-08 | 2013-03-06 | 4 | CAUWENBERGH GEERT | RXII | Common Stock | D | 0,1450 | 250 000 | 36 | 250 000 | ||||
| 2013-03-01 | 3 | Pavco Pamela | RXII | Common stock, par value $0.0001 | D | 90 153 | ||||||||
| 2013-03-01 | 3 | Galena Biopharma, Inc. | RXII | Common stock, $0.0001 par value | D | 33 476 595 | ||||||||
| 2013-03-01 | 3 | Kontulis Caitlin | RXII | Common stock, par value $0.0001 | D | 2 231 |
P
Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych
S
Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych
A
Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)
C
Konwersja instrumentu pochodnego
D
Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki
F
Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki
G
Darowizna papierów wartościowych przez lub na rzecz insidera
K
Swapy kapitałowe i podobne transakcje zabezpieczające
M
Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)
V
Transakcja dobrowolnie zgłoszona na Formularzu 4
J
Inne (wraz z przypisem opisującym transakcję)
